T1	Participants 427 726	total of 2,802 men 50 years or older with a clinical diagnosis of benign prostatic hyperplasia, no history of prostate cancer, PSA 1.5 to 10 ng/ml, prostate volume 30 cc or greater, an American Urological Association symptom score of 12 or greater and peak urinary flow rate 15 ml per second or less
T2	Participants 1861 1879	men on dutasteride
T3	Participants 1907 1932	men receiving dutasteride
